MicroPort Orthopedics Focuses on Portfolio Expansion During COVID Slowdown

MicroPort Orthopedics reported orthopedic revenue of USD $86.6 million, -23.6% vs. 1H19. With only about 11% of its revenue coming from the domestic Chinese market, the company had significant exposure to COVID-related procedure deferrals in the first half. These deferrals offset better than expected momentum at the beginning of the year....

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us